Fountain Healthcare is a venture capital firm dedicated to the life sciences sector, focusing on investments in specialty pharmaceuticals, biotechnology, medical devices, and diagnostics. Their strategy involves building a balanced portfolio of early-stage companies with disruptive technologies, providing strategic guidance, and typically leading or co-leading investments primarily in Europe and the US.
50% of their portfolio is in Healthcare. Deal activity increased 50% year-over-year (3 deals in the last 12 months). Their most common stage is series-b (62% of deals). Average disclosed round size is $49.2M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
$425M
Top Stage
Series B
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Neurent Medical | Series C | — | Feb 2026 |
| Neurent Medical | Series C | $74M | Feb 2026 |
 Exciva | Series B | $59M | Jan 2026 |
| EExciva GmbH | Series B | $59M | Jan 2025 |
 XyloCor Therapeutics | Series B | $67.5M | Jan 2025 |
| DDualyx | Series A | $44M | May 2023 |
 Neuromod Devices Ltd | Series B | $30M | Apr 2023 |
| Neuromod Devices Ltd | Series B | $10.8M | — |
Top Co-Investors
EQT Life Sciences4 shared
Andera Partners3 shared
Gimv2 shared
LifeArc Ventures2 shared
Carma Fund2 shared
LBBW Venture Capital2 shared
Sofinnova Partners2 shared
Atlantic Bridge2 shared
Enterprise Ireland2 shared
Jeito Capital1 shared
EQT Ventures1 shared
European Investment Bank1 shared
Forbion1 shared
BGV1 shared
PMV1 shared
HTGF1 shared
Last updated: 16 April 2026